Effect of 1,25-dihydroxyvitamin D3 on calcium and magnesium absorption in the healthy human jejunum and ileum

      This paper is only available as a PDF. To read, Please Download here.


      In calcium deficiency states such as chronic renal failure, 1,25-dihydroxyvitamin D3 increases calcium and magnesium absorption toward normal levels. In the present study, the ability of exogenous 1,25-dihydroxyvitamin D3 to increase calcium and magnesium absorption above normal rates in healthy subjects was investigated. Steady-state perfusion studies were performed in 30 cm segments of jejunum and ileum before and after one week of 1,25-dihydroxyvitamin D3 administration (2 μg per day, 10 subjects). Serum 1,25-dihydroxyvitamin D concentration increased from 25.8 ± 2.5 pg/ml to 56.4 ± 6.6 (mean ± SEM, p < 0.05). In the basal state, calcium absorption was significantly higher in the jejunum than in the ileum. Vitamin D administration resulted in a significant increase in calcium absorption which was quantitatively similar in both the jejunum and ileum. The changes in net movement were due to an increase in lumen-to-plasma flux of calcium; the plasma-to-lumen flux remained unchanged. Jejunal magnesium absorption also was enhanced by 1,25-dihydroxyvitamin D3. These studies demonstrate that in healthy persons, exogenous 1,25-dihydroxyvitamin D3 increases calcium absorption in both the jejunum and the ileum, and increases magnesium absorption in the jejunum.
      To read this article in full you will need to make a payment


        • Lawson D
        • Fraser DR
        • Kodicek E
        Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism.
        Nature. 1971; 230: 228-230
        • Holick MF
        • Schnoes HK
        • DeLuca HF
        • Suda T
        • Cousins RJ
        Isolation and identification of 1,25-dihydroxycholecalciferol: a metabolite of D active in the intestine.
        Biochemistry. 1971; 10: 2799-2804
        • Schmulen C
        • Lerman M
        • Pak CYC
        • et al.
        Effect of 1,25-dihydroxyvitamin D3 therapy on intestinal absorption of magnesium in patients with chronic renal disease.
        Am J Physiol. 1980; 1: G349-G352
        • Norman DA
        • Fordtran JS
        • Brinkley LJ
        • et al.
        Jejunal and ileal adaptation to alterations in dietary calcium. Changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D.
        J Clin Invest. 1981; 67: 1599-1603
        • Brannan PG
        • Morawski S
        • Pak CYC
        • Fordtran JS
        Selective jejunal hyperabsorption of calcium in absorptive hypercalciuria.
        Am J Med. 1979; 66: 425-428
        • Kaplan RA
        • Haussler MR
        • Deftos LJ
        • Bone H
        • Pak CYC
        The role of 1 α, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
        J Clin Invest. 1977; 59: 756-760
        • Shen FH
        • Baylink DJ
        • Nielson RL
        • Sherrard DJ
        • Ivey JL
        • Haussler MR
        Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria.
        J Lab Clin Med. 1977; 90: 955-962
        • Gray RW
        • Wilz DR
        • Caldas AE
        • Lemann Jr, J
        The importance of phosphate in regulative plasma 1,25-(OH)2 vitamin D levels in humans: studies in healthy subjects, in calciumstone formers and in patients with primary hyperparathyroidism.
        J Clin Endocrinol Metab. 1977; 45: 299-306
        • Schwille PO
        • Scholz D
        • Engelhardt W
        Is increased intestinal calcium absorption in human calcium urolithiasis a feature of a hormonal imbalance?.
        Hepatogastroenterology. 1981; 28: 131-134
        • Brannan PG
        • Vergne-Marini P
        • Pak CYC
        • Hull AR
        • Fordtran JS
        Magnesium absorption in the human small intestine. Results in normal subjects, patients with chronic renal disease, and patients with absorptive hypercalciuria.
        J Clin Invest. 1976; 57: 1412-1418
        • Gray RW
        • Caldas AE
        • Wilz DR
        • Lemann J
        • Smith GA
        • DeLuca HF
        Metabolism and excretion of 3H-1,25-(OH)2-vitamin D3 in healthy adults.
        J Clin Endocrinol Metab. 1978; 46: 756-765
        • Krejs GJ
        • Walsh JH
        • Morawski SG
        • Fordtran JS
        Intractable diarrhea: intestinal perfusion studies and plasma VIP concentrations in patients with pancreatic cholera syndrome and surreptitious ingestion of laxatives and diuretics.
        Am J Dig Dis. 1977; 22: 280-292
        • Krejs GJ
        • Hendler RS
        • Fordtran JS
        Diagnostic and pathophysiologic studies in patients with chronic diarrhea.
        in: Field M Secretory diarrhea. American Physiological Society, Bethesda1980: 141-151
        • Krejs GJ
        • Fordtran JS
        Effect of VIP infusion on water and ion transport in the human jejunum.
        Gastroenterology. 1980; 78: 722-727
        • Fordtran JS
        • Rector FC
        • Ewton MF
        • Soter N
        • Kinney J
        Permeability characteristics of the human small intestine.
        J Clin Invest. 1965; 44: 1935-1944
        • Krejs GJ
        • Fordtran JS
        Physiology and pathophysiology of ion and water movement in the human intestine.
        in: Sleisenger M Fordtran JS Gastrointestinal disease. 2nd ed. WB Saunders, Philadelphia1978: 297-335
        • Krejs GJ
        • Seelig LL
        • Fordtran JS
        Effect of protonated 2,4,6-triaminopyrimidine, a “tight junction blocker,” on intestinal transport in dog ileum in vivo.
        Gastroenterology. 1977; 72: 685-691
        • Berger EY
        • Steele JM
        The calculation of transfer rates in two compartment systems not in dynamic equilibrium.
        J Gen Physiol. 1958; 41: 1135-1152
        • Breslau NA
        • Zerwekh JE
        • Nicar MJ
        • Pak CYC
        Effects of short term glucocorticoid administration in primary hyperparathyroidism: comparison to sarcoidosis.
        J Clin Endocrinol Metab. 1982; 54: 824-830
        • Zerwekh JE
        • Nicar MJ
        • Skurla C
        • Savjani G
        Serum immunoreactive parathyroid hormone: optimization of Diagnostic Systems Laboratories, Inc. iPTH assay (abstr).
        Clin Chem. 1982; 28: 1556